Induction of the GαqSignaling Cascade by the Human Immunodeficiency Virus Envelope Is Required for Virus Entry
- 15 September 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (18), 9191-9205
- https://doi.org/10.1128/jvi.00424-08
Abstract
Binding of human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein (Env) with the primary receptor CD4 and one of two coreceptors, CXCR4 or CCR5, activates a signaling cascade resulting in Rac-1 GTPase activation and stimulation of actin cytoskeletal reorganizations critical for HIV-1-mediated membrane fusion. The mechanism by which HIV-1 Env induces Rac-1 activation and subsequent actin cytoskeleton rearrangement is unknown. In this study, we show that Env-mediated Rac-1 activation is dependent on the activation of Gαq and its downstream targets. Fusion and Rac-1 activation are mediated by Gαq and phospholipase C (PLC), as shown by attenuation of fusion and Rac-1 activation in cells either expressing small interfering RNA (siRNA) targeting Gαq or treated with the PLC inhibitor U73122. Rac-1 activation and fusion were also blocked by multiple protein kinase C inhibitors, by inhibitors of intracellular Ca2+ release, by Pyk2-targeted siRNA, and by the Ras inhibitor S-trans,trans-farnesylthiosalicylic acid (FTS). Fusion was blocked without altering cell viability or cell surface localization of CD4 and CCR5. Similar results were obtained when cell fusion was induced by Env expressed on viral and cellular membranes and when cell lines or primary cells were the target. Treatment with inhibitors and siRNA specific for Gαi or Gαs signaling mediators had no effect on Env-mediated Rac-1 activation or cell fusion, indicating that the Gαq pathway alone is responsible. These results could provide a new focus for therapeutic intervention with drugs targeting host signaling mediators rather than viral molecules, a strategy which is less likely to result in resistance.Keywords
This publication has 73 references indexed in Scilit:
- Antiviral activity of a Rac GEF inhibitor characterized with a sensitive HIV/SIV fusion assayVirology, 2007
- Targeting the protein kinase C family: are we there yet?Nature Reviews Cancer, 2007
- The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophagesVirus Research, 2006
- The Ras Inhibitor Farnesylthiosalicylic Acid as a Potential Therapy for Neurofibromatosis Type 1Clinical Cancer Research, 2006
- HIV-1 gp120 Compromises Blood–Brain Barrier Integrity and Enhance Monocyte Migration across Blood–Brain Barrier: Implication for Viral NeuropathogenesisJournal of Cerebral Blood Flow & Metabolism, 2006
- Tiam1-IRSp53 Complex Formation Directs Specificity of Rac-Mediated Actin Cytoskeleton RegulationMolecular and Cellular Biology, 2005
- Actin Cytoskeletal Reorganizations and Coreceptor-Mediated Activation of Rac during Human Immunodeficiency Virus-Induced Cell FusionJournal of Virology, 2004
- Rac Activation Induces NADPH Oxidase Activity in Transgenic COS Cells, and the Level of Superoxide Production Is Exchange Factor-dependentJournal of Biological Chemistry, 2002
- HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin–insensitive chemokine receptor signalingBlood, 2001
- HIV-1 Entry and Macrophage Inflammatory Protein-1β-mediated Signaling Are Independent Functions of the Chemokine Receptor CCR5Published by Elsevier ,1997